Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today that a presentation related to Peyronie's disease, or PD, and XIAFLEX® (collagenase clostridium histolyticum, or CCH, injection 0.9 ...

Xiaflex was approved in 2010 for the treatment of Dupuytren’s contracture. Dupuytren’s contracture is a condition where nodules form under the skin in the palm of the hand. These nodules thicken and ...

If you’ve been diagnosed with Peyronie’s disease or Dupuytren’s contracture, your doctor might suggest Xiaflex as a treatment option for you. It’s a prescription drug used in adults to treat these ...

Xiaflex (collagenase clostridium histolyticum) is a brand-name injection that’s prescribed for Peyronie’s disease and Dupuytren’s contracture in adults. As with other drugs, Xiaflex can cause side ...

Auxilium Pharmaceuticals (AUXL) Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture XIAFLEX Also Meets ...

If you have Dupuytren’s contracture or Peyronie’s disease, your doctor may suggest treatment with Xiaflex. This is a prescription medication used to treat these two conditions in adults in certain ...

The Food and Drug Administration (FDA) has approved Xiaflex as the first non-surgical treatment for Peyronie’s disease (PD), a condition that causes penis curvature that can make sexual intercourse ...

MALVERN, Pa., Feb. 3 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, just announced that it has received marketing approval from the U.S. Food and ...

-- First Commercial Sale Triggers $20 Million Milestone Payment to Endo -- DUBLIN, Aug. 31, 2015 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that XIAFLEX® ...

−Safety Profile Consistent with Clinical Trials after approximately 27,000 injections administered in U.S. through July 31, 2012− MALVERN, Pa., Sept. 5, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, ...